Cogent Biosciences, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $313.4M
Liabilities Breakdown FY2023
Total Liabilities: $55.6M
Asset Breakdown
Total Assets: $313.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $53.2M | 17.0% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $8.3M | 2.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $251.9M | 80.4% |
Liabilities Breakdown
Total Liabilities: $55.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $10.7M | 19.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $45.0M | 80.8% |